Jones Financial Companies’s Repare Therapeutics RPTX Stock Holding History

Jones Financial Companies’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-100	Closed	-$260	–	4892
2025 Q4	$260	Hold	100	–	–	﹤0.01%	4246
2025 Q3	$169	Hold	100	–	–	﹤0.01%	4140
2025 Q2	$139	Hold	100	–	–	﹤0.01%	3933
2025 Q1	$105	Hold	100	–	–	﹤0.01%	3624
2024 Q4	$131	Buy	+100	New	+$298	﹤0.01%	3333

Jones Financial Companies's RPTX Position: Q1 2026 in Review

Jones Financial Companies sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 100 shares — an estimated $260 sold.

Jones Financial Companies first reported a position in RPTX in Q4 2024 and held it in 5 quarters. The position peaked at $260 in Q4 2025. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

Jones Financial Companies reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
Jones Financial Companies sold 100 Repare Therapeutics shares in Q1 2026, an estimated $260.
Jones Financial Companies first reported a position in Repare Therapeutics in Q4 2024 and held it in 5 quarters.
Jones Financial Companies's Repare Therapeutics position peaked at $260 in Q4 2025.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.